Cargando…
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events
OBJECTIVE: Women with multiple sclerosis are often diagnosed and treated during their reproductive years. Limited data are available on the safety of treatment during pregnancy. The Betaseron Pregnancy Registry prospectively monitored women exposed to interferon β-1b (IFNβ-1b) during pregnancy to es...
Autores principales: | Coyle, P K, Sinclair, S M, Scheuerle, A E, Thorp, J M, Albano, J D, Rametta, M J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025462/ https://www.ncbi.nlm.nih.gov/pubmed/24821713 http://dx.doi.org/10.1136/bmjopen-2013-004536 |
Ejemplares similares
-
74. Maternal Dolutegravir (DTG) Use During Pregnancy and Birth Outcomes: The Antiretroviral Pregnancy Registry (APR)
por: Vannappagari, Vani, et al.
Publicado: (2021) -
Pregnancy characteristics and adverse outcomes in offspring of women with epilepsy: a prospective registry study from Mainland China
por: Li, Rui, et al.
Publicado: (2023) -
Assessing the risk of birth defects associated with atazanavir exposure in pregnancy
por: Esker, S, et al.
Publicado: (2010) -
Birth defect co-occurrence patterns in the Texas Birth Defects Registry
por: Benjamin, Renata H., et al.
Publicado: (2022) -
Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry
por: Vannappagari, V, et al.
Publicado: (2015)